0000899243-23-010034.txt : 20230330
0000899243-23-010034.hdr.sgml : 20230330
20230330175518
ACCESSION NUMBER: 0000899243-23-010034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230329
FILED AS OF DATE: 20230330
DATE AS OF CHANGE: 20230330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brand Florian
CENTRAL INDEX KEY: 0001860682
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40493
FILM NUMBER: 23782070
MAIL ADDRESS:
STREET 1: C/O ATAI LIFE SCIENCES N.V.
STREET 2: 180 VARICK STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences N.V.
CENTRAL INDEX KEY: 0001840904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: WALLSTRASSE 16
CITY: BERLIN
STATE: 2M
ZIP: 10179
BUSINESS PHONE: (617)-699-5876
MAIL ADDRESS:
STREET 1: 524 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: ATAI Life Sciences B.V.
DATE OF NAME CHANGE: 20210115
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-29
0
0001840904
ATAI Life Sciences N.V.
ATAI
0001860682
Brand Florian
WALLSTRASSE 16
BERLIN
2M
10179
GERMANY
0
1
0
0
See Remarks
0
Common Shares
2023-03-29
4
P
0
70000
1.4794
A
70000
D
Common Shares
2333
I
By Spouse
The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.40 to $1.55. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
Co-Founder & Chief Executive Officer
/s/ Ryan Barrett, Attorney-in-fact
2023-03-30